Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

25.06.21	Bristol Myers Gets Positive CHMP Opinion For Abecma On Relapsed & Refractory Multiple Myeloma (RTTNews)
25.06.21	Bristol Myers Gets Positive CHMP Opinion For Opdivo To Treat Esophageal Cancer (RTTNews)
24.06.21	Prothena To Receive $80 Mln From Bristol Myers For US License To PRX005 On Alzheimer's Disease (RTTNews)
18.06.21	Bristol Myers Enters Into Collaboration For Eisai's MORAb-202 Antibody Drug Conjugate (RTTNews)
14.06.21	Exelixis, Bristol Myers To Evaluate XL092-Immuno-oncology Therapies In Advanced Solid Tumors (RTTNews)
11.06.21	BMY, Acceleron Announce New Data From Reblozyl Phase 2 Trial For Adults With NTD Beta Thalassemia (RTTNews)
10.06.21	BMY Reports Positive Results From Phase 3 Breyanzi Trial In Second-line Relapsed Or Refractory LBCL (RTTNews)
02.06.21	Health Canada Approves Bristol Myers' Opdivo Plus Yervoy To Treat Mesothelioma - Quick Facts (RTTNews)
02.06.21	EC Approves Bristol Myers' Opdivo Plus Yervoy To Treat Mesothelioma - Quick Facts (RTTNews)
25.05.21	Xencor, Bristol Myers Ink License Deal To Use Xtend XmAb Technology To Treat COVID-19 - Quick Facts (RTTNews)
18.05.21	Agenus Grants Bristol Myers Squibb License To Bispecific Antibody Program, AGEN1777 - Quick Facts (RTTNews)
29.04.21	Bristol Myers Squibb Q1 Profit Misses Estimates (RTTNews)
23.04.21	Bristol Myers Gets Positive CHMP Opinion For Opdivo Plus Yervoy As First-Line Treatment For MPM (RTTNews)
19.04.21	First FDA-approved Immunotherapy For First Treatment Of Gastric Cancer (RTTNews)
14.04.21	Bristol Myers' Nivolumab Approved By EU For Kidney Cancer Treatment (RTTNews)
29.03.21	FDA Approves First Cell-Based Gene Therapy For Adult Multiple Myeloma Patients (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
25.03.21	Bristol Myers Squibb Announces Positive Results For Relativity-047 Study- Quick Facts (RTTNews)
12.03.21	AVEO, Bristol Myers To Evaluate Fotivda - Opdivo In Phase 3 Trial In Relapsed Renal Cell Carcinoma (RTTNews)
16.02.21	Bristol-Myers, Sanofi Ordered To Pay $834 Mln Over Plavix In Hawaii (RTTNews)
08.02.21	FDA OKs Bristol-Myers Squibb's Breyanzi To Treat Large-B-Cell Lymphoma (RTTNews)
04.02.21	Bristol-Myers Squibb Co. Q4 adjusted earnings Beat Estimates (RTTNews)
04.02.21	Bristol Myers Squibb Raises 2021 Adj. Earnings Guidance (RTTNews)
11.01.21	Amgen, AstraZeneca, Bristol Myers Squibb To Evaluate GRAIL's Cancer Early Detection Test (RTTNews)
11.01.21	Bristol Myers Board Authorizes Incremental Share Repurchase - Quick Facts (RTTNews)
05.01.21	Evotec Receives $6 Mln Payment From Bristol Myers On IPSC-based Neuroscience Partnership (RTTNews)
28.12.20	Bristol Myers Squibb: EMA Validates Marketing Authorization Application For Zeposia (RTTNews)
28.12.20	Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? (RTTNews)
23.12.20	Bristol-Myers: Phase 3 CheckMate -548 Trial Will Not Meet Primary Endpoint Of Overall Survival (RTTNews)
17.12.20	Evotec Meets Key Milestones In Partnership With Bristol Myers On Targeted Protein Degradation (RTTNews)
11.12.20	Bristol Myers' Celgene, Cipla Settle U.S. Patent Litigation On Lenalidomide (RTTNews)
23.11.20	Schrdinger Enters Into Discovery Collaboration With Bristol Myers Squibb - Quick Facts (RTTNews)
17.11.20	Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise (Businesswire)
17.11.20	ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective (RTTNews)
15.11.20	Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) (RTTNews)
05.11.20	Bristol Myers Squibb Raises FY20 Earnings Guidance - Quick Facts (RTTNews)
04.11.20	Bristol Myers - MyoKardia Deal Receives U.S. Regulatory Approval (RTTNews)
04.11.20	Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period (Businesswire)
02.11.20	Will Eiger's Zokinvy Make History To Become First-ever Progeria Treatment? (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
08.10.20	Evotec, Bristol Myers Expand Neuroscience Partnership; Evotec Gains Milestone Payment (RTTNews)
07.10.20	Opdivo Plus Chemotherapy As Neoadjuvant Treatment In Resectable NSCLC Trial Hits Key Goal, Says BMY (RTTNews)
07.10.20	Canada Approves Bristol-Myers' Zeposia To Treat Relapsing Remitting Multiple Sclerosis (RTTNews)
05.10.20	Bristol Myers Snaps Up MyoKardia For $225/Share (RTTNews)
05.10.20	Bristol Myers Squibb To Buy MyoKardia For $13.1 Bln In Cash - Quick Facts (RTTNews)
05.10.20	Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash (Businesswire)
05.10.20	FDA Approves Drug Combination To Treat Mesothelioma (RTTNews)
29.09.20	Bristol Myers, Acceleron Pharma Announce Health Canada Approval Of Reblozyl (RTTNews)
17.09.20	Celgene, Dr. Reddy's Reach Settlement Agreement On Patents For REVLIMID Capsules (RTTNews)
27.08.20	Biotech Stocks Facing FDA Decision In September (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		S&P 500-Wert Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 10 Jahren verloren
19.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: So viel hätten Anleger mit einem Investment in Merck von vor 10 Jahren verdient
19.11.24		Angespannte Stimmung in New York: Dow Jones liegt zum Handelsstart im Minus
19.11.24		Verluste in Europa: STOXX 50 mit Abgaben

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

S&P 500-Wert Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 10 Jahren verloren

19.11.24

Dow Jones 30 Industrial-Papier Merck-Aktie: So viel hätten Anleger mit einem Investment in Merck von vor 10 Jahren verdient

19.11.24

Angespannte Stimmung in New York: Dow Jones liegt zum Handelsstart im Minus

19.11.24

Verluste in Europa: STOXX 50 mit Abgaben

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Bristol-Myers Squibb Co.

Aktien Top/Flop

Bristol-Myers Squibb Peer Group Nachrichten

Meistgelesene Nachrichten